Data / Form D filings / REATA PHARMACEUTICALS INC
REATA PHARMACEUTICALS INC: Form D filings
REATA PHARMACEUTICALS INC, a biotechnology company in Plano, TX, filed 5 Form D notices with the SEC between 2009 and 2020. The latest, on June 25, 2020, reports $50 million sold of a $50 million offering to 2 investors.
Find out what REATA PHARMACEUTICALS INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5320 LEGACY DRIVE, Plano, TX, 75024
- Phone
- (972) 865-2219
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1358762
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2020 | New notice | $50,000,000 | $50,000,000 | $0 | 2 | Jun 24, 2020 | sec.gov |
| Jul 13, 2011 | New notice | $300,000,000 | $300,000,000 | $0 | 1 | Nov 10, 2010 | sec.gov |
| Oct 5, 2010 | New notice | $79,333,335 | $16,977,840 | $62,355,495 | 30 | Sep 15, 2009 | sec.gov |
| Feb 26, 2010 | New notice | $1,972,000 | $1,972,000 | $0 | 1 | Feb 15, 2010 | sec.gov |
| Sep 28, 2009 | New notice | $79,333,335 | $16,977,840 | $62,355,495 | 30 | Sep 15, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael D. Wortley | Executive Officer | |
| Manmeet S. Soni | Executive Officer | |
| Colin J. Meyer, M.D. | Executive Officer | |
| William D. McCLellan, Jr. | Director | |
| J. Kent McGaughy, Jr. | Director | |
| Jack B. Nielsen | Director | |
| Dawn C. Bir | Executive Officer | |
| James E. Bass | Director | |
| William E. Rose | Director | |
| J. Warren Huff | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jun 22, 2020 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what REATA PHARMACEUTICALS INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.